Pila Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15.9	4.89	5.95	7.24	28.21
Cash & Short-Term Investments	15.9	4.89	5.95	7.24	28.21
Cash Growth	224.90%	-17.82%	-17.79%	-74.33%	1379.11%
Accounts Receivable	-	-	0.05	-	-
Other Receivables	0.14	0.07	0.23	0.2	0.15
Receivables	0.14	0.07	0.28	0.2	0.15
Prepaid Expenses	0.11	0.05	0.01	0.14	0.14
Total Current Assets	16.15	5.01	6.24	7.59	28.5
Property, Plant & Equipment	-	-	-	-	0.02
Long-Term Investments	0.07	0.07	0.07	0.07	0.07
Other Intangible Assets	-	1.08	2.15	3.23	3.23
Other Long-Term Assets	-	0.07	-	-	-
Total Assets	16.22	6.22	8.46	10.89	31.81
Accounts Payable	0.23	0.44	0.4	0.35	0.35
Accrued Expenses	0.87	0.48	0.13	0.69	0.59
Current Income Taxes Payable	-	-	0.13	0.13	0.04
Other Current Liabilities	0.47	0.04	1.14	0.19	0.53
Total Current Liabilities	1.57	0.96	1.79	1.36	1.51
Total Liabilities	1.57	0.96	1.79	1.36	1.51
Common Stock	1.8	1.16	1.02	0.79	0.69
Additional Paid-In Capital	123.33	97.59	87.89	81.06	75.14
Retained Earnings	-110.49	-93.48	-82.24	-72.31	-45.54
Shareholders' Equity	14.65	5.26	6.66	9.53	30.3
Total Liabilities & Equity	16.22	6.22	8.46	10.89	31.81
Net Cash (Debt)	15.9	4.89	5.95	7.24	28.21
Net Cash Growth	224.90%	-17.82%	-17.79%	-74.33%	1904.68%
Net Cash Per Share	0.46	0.19	0.28	0.42	2.16
Filing Date Shares Outstanding	42.08	27.13	23.79	18.41	16.1
Total Common Shares Outstanding	42.08	27.13	23.79	18.41	16.1
Working Capital	14.58	4.05	4.44	6.23	26.98
Book Value Per Share	0.35	0.19	0.28	0.52	1.88
Tangible Book Value	14.65	4.18	4.51	6.3	27.06
Tangible Book Value Per Share	0.35	0.15	0.19	0.34	1.68
Machinery	0.1	0.1	-	-	0.1